Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Unlike stimulants such as phentermine, GLP-1s may aid in weight loss while also improving blood sugar control
Coverage for tirzepatide-based therapies such as Mounjaro or ZepBound may also vary depending on whether the patient has diabetes or meets eligibility criteria for obesity treatment
Researchers tracking retatrutide appetite suppression should be prepared for a similar or slightly elevated sulfur burp profile compared to dual agonists
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Management Tips: Prioritize adequate rest and a balanced diet
Your Med+ Care Team will work directly with your insurance provider to help you navigate your coverage of Wegovy
US$ 29.01
US$ 25.50
US$ 21.72
